Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus
about
Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causationRegulation of the visna virus long terminal repeat in macrophages involves cellular factors that bind sequences containing AP-1 sitesPathogenesis of human immunodeficiency virus infectionSequences in the visna virus long terminal repeat that control transcriptional activity and respond to viral trans-activation: involvement of AP-1 sites in basal activity and trans-activationVisna virus exhibits a complex transcriptional pattern: one aspect of gene expression shared with the acquired immunodeficiency syndrome retrovirusRetroviral coinfections: HIV and HTLV: taking stock of more than a quarter century of researchNeutralizing antibodies to visna lentivirus: mechanism of action and possible role in virus persistenceHuman immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cellsPPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptaseAntiretroviral activities of protease inhibitors against murine leukemia virus and simian immunodeficiency virus in tissue cultureComputer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions.Ultrastructural pathology of human immunodeficiency virus infection.Human immunodeficiency virus (HIV) transcripts identified in HIV-related psoriasis and Kaposi's sarcoma lesions.Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes.Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.Nucleotide sequence and transcriptional activity of the caprine arthritis-encephalitis virus long terminal repeatPrevention of simian acquired immune deficiency syndrome with a formalin-inactivated type D retrovirus vaccine.Isolation of a lentivirus from a macaque with lymphoma: comparison with HTLV-III/LAV and other lentiviruses.Cytomegalovirus but not human T lymphotropic virus type III/lymphadenopathy associated virus detected by in situ hybridisation in retinal lesions in patients with the acquired immune deficiency syndrome.Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector.Inhibitory effect of 9-(2-phosphonylmethoxyethyl)adenine on visna virus infection in lambs: a model for in vivo testing of candidate anti-human immunodeficiency virus drugs.Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies.Demonstration of defective C3-receptor-mediated clearance by the reticuloendothelial system in patients with acquired immunodeficiency syndrome.Infection of monocyte/macrophages by human T lymphotropic virus type III.Fusion as a mediator of cytolysis in mixtures of uninfected CD4+ lymphocytes and cells infected by human immunodeficiency virusBroad spectrum antiretroviral activity of 2',3'-dideoxynucleosidesHuman retroviruses after 20 years: a perspective from the past and prospects for their future control.Rev response elements (RRE) in lentiviruses: an RNAMotif algorithm-based strategy for RRE prediction.A model-based approach for estimating the mean incubation period of transfusion-associated acquired immunodeficiency syndromeHuman T-cell lymphotropic virus type III shares sequence homology with a family of pathogenic lentiviruses.The neuropathology of pediatric acquired immunodeficiency syndrome.Important factors for testing barrier materials with surrogate viruses.Opportunistic infections in acquired immune deficiency syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity.Lentivirus-induced lymphoproliferative disease. Comparative pathogenicity of phenotypically distinct ovine lentivirus strains.The neuropathology of AIDS. UCLA experience and review.Ovine lentivirus lymphoid interstitial pneumonia. Rapid induction in neonatal lambs.Stability of RNA stem-loop structure and distribution of non-random structure in the human immunodeficiency virus (HIV-I).Somatic Populations of PGT135-137 HIV-1-Neutralizing Antibodies Identified by 454 Pyrosequencing and BioinformaticsCytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV diseaseHIV pathogenesis: knowledge gained after two decades of research.
P2860
Q24627627-A04B1DA1-734B-4E51-A422-8630FC6979ECQ24634385-4DFCD3CA-E56A-4680-B397-979DC5E9AD65Q24634681-9EB14181-3328-4B9D-8371-8494AB51E8CCQ24645645-A1D763BB-2CB1-49C1-9C08-F7BFC9BB5744Q24648639-AC0282CE-675D-44D0-9DA4-83B22254FF55Q26853678-02B599E0-1CBE-49D6-B972-62A194CEB325Q27486808-A11F1218-27DB-45EC-AB00-E5F7D449C581Q28318483-0A526558-BBE3-4ED7-AFC1-217C992FBEBCQ28336988-1B6992EE-8474-44DC-A200-ADB5E5651194Q28378612-C19EB754-44C9-4FA3-8DD4-8E7D3462AF1DQ30356755-F3D03A67-34B9-4D57-8CA6-1A2114C4CFD3Q33209535-3CBA340D-2394-4AB7-BEBC-04BDB8CD6698Q33246074-D3BB46F8-1F86-4141-9CB0-A60AE72A35DAQ33645169-4AB5C608-53F0-4E94-A903-8C3C8FDA4BB2Q33804495-6E0B3768-A2DA-4AC1-A94A-B9105B1A8103Q33927006-285890F0-777C-48EE-845F-83468A36E4B6Q33927302-E93F2387-CE4A-4419-BF62-7EC7026EC9D3Q33927613-89957126-CA62-4858-A9FE-425AE8214598Q34287297-2B0BAED2-0439-4F3D-AE5C-EBD77DBA4C35Q34320065-D1383438-289E-4189-ADF0-C20437384DDFQ34429807-D5EB3C23-028A-4D5A-9D6B-9BC2A42C1FB1Q34553676-E8B8D19D-45EC-459B-9B40-A5797A7A0F69Q34562918-8F5D2046-2299-4D51-B500-4FDE6B77D78BQ34579117-88FEE057-D0D7-4BE2-A456-B46326EA6589Q34603040-716CF1AF-7C2B-484C-9851-3D4242FC7F06Q34614908-7C26716D-1F6F-4D27-A001-CC64CF7811F9Q34792498-1808CA7D-C5B3-44C2-8CDE-AB894547F18FQ34944502-6CA2B57E-D4F8-4563-A446-64DEDEB9E6DBQ35603582-67AA3785-19C1-4DF8-A055-960EDFF8990BQ35609332-E0749683-99FF-44E2-9023-153D53FE70FCQ35614482-9294242C-124E-47DE-80B2-050B442E1DA6Q35710366-A03B3F1C-E1A9-491C-B929-12E7434AF5EAQ35807942-1312C23F-E6F8-441D-8E0E-C6177858BD2DQ35818311-4D5304FF-6F5C-4D06-8351-FD8A2219EE08Q35836258-2BF6560B-B34A-4252-9FBF-055C0B6CD5F8Q35836527-D953B8AF-8146-4B34-BA0E-ADF364354777Q36008291-D204F2AC-1842-42E1-A466-D76D0AFFCF8AQ36231944-50FBE6B1-B436-48B9-90C4-3502B9655C5FQ36232123-BF4A0335-3F59-44E6-989C-0A830EB63344Q36467649-AE2E7D9E-2CF8-4E2D-8EC6-ADA54331D89D
P2860
Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus
description
1985 nî lūn-bûn
@nan
1985 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Sequence homology and morpholo ...... virus, a pathogenic lentivirus
@ast
Sequence homology and morpholo ...... virus, a pathogenic lentivirus
@en
Sequence homology and morpholo ...... virus, a pathogenic lentivirus
@nl
type
label
Sequence homology and morpholo ...... virus, a pathogenic lentivirus
@ast
Sequence homology and morpholo ...... virus, a pathogenic lentivirus
@en
Sequence homology and morpholo ...... virus, a pathogenic lentivirus
@nl
prefLabel
Sequence homology and morpholo ...... virus, a pathogenic lentivirus
@ast
Sequence homology and morpholo ...... virus, a pathogenic lentivirus
@en
Sequence homology and morpholo ...... virus, a pathogenic lentivirus
@nl
P2093
P356
P1433
P1476
Sequence homology and morpholo ...... virus, a pathogenic lentivirus
@en
P2093
F Wong-Staal
J E Clements
R V Gilden
P356
10.1126/SCIENCE.2981428
P407
P50
P577
1985-01-11T00:00:00Z